Chemo benefits patients after nephroureterectomy in UTUC

January 6, 2017

(HealthDay)—For patients undergoing radical nephroureterectomy (RNU) for pT3/T4 and/or pN+ upper tract urothelial carcinoma (UTUC), adjuvant chemotherapy (AC) use is associated with an overall survival benefit, according to a study published online Jan. 3 in the Journal of Clinical Oncology.

Thomas Seisen, M.D., from Brigham and Women's Hospital in Boston, and colleagues identified 3,253 individuals within the National Cancer Database who received AC or observation after RNU for pT3/T4 and/or pN+ UTUC. Overall survival (OS) was compared for patients in the two treatment groups.

The researchers found that after RNU, 762 (23.42 percent) and 2,491 (76.58 percent) patients with pT3/T4 and/or pN+ UTUC received AC and observation, respectively. Median OS was significantly longer for AC versus observation (47.41 versus 35.78 months) in inverse probability of treatment weighting (IPTW)-adjusted Kaplan-Meier curves. For AC versus observation, the five-year IPTW-adjusted rates of OS were 43.90 and 35.85 percent, respectively. AC correlated with a significant OS benefit in IPTW-adjusted Cox proportional hazards regression analysis (hazard ratio, 0.77). Across all subgroups this benefit was consistent, with no significant heterogeneity of effect.

"Although our results are limited by the usual biases related to the observational study design, we believe that the present findings should be considered when advising post-RNU management of advanced UTUC, pending level I evidence," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Adjuvant chemo plus CRT best in nasopharyngeal carcinoma

More information: Full Text

Related Stories

Adjuvant chemo plus CRT best in nasopharyngeal carcinoma

December 19, 2016
(HealthDay)—For nonmetastatic nasopharyngeal carcinoma, the addition of adjuvant chemotherapy (AC) to chemoradiotherapy (CRT) is associated with the highest survival benefit, according to research published online Dec. ...

Post-operative radiation therapy improves overall survival for patients with resected NSCLC

October 30, 2014
Patients who received post-operative radiation therapy (PORT), radiation therapy after surgery, lived an average of four months longer when compared to the patients who had the same disease site, tumor histology and treatment ...

CRT may be preferred strategy for elderly with lung cancer

October 22, 2015
(HealthDay)—Chemoradiotherapy (CRT) is associated with survival benefit over chemotherapy (CT) alone for elderly patients with limited-stage small-cell lung cancer, according to a study published online Oct. 19 in the Journal ...

Cystectomy plus chemo ups survival in bladder cancer

January 21, 2016
(HealthDay)—For patients with locally advanced bladder cancer, cystectomy plus adjuvant chemotherapy is associated with improved survival versus cystectomy alone, according to a study published online Jan. 19 in the Journal ...

Intraperitoneal chemo offers lasting benefit in ovarian cancer

March 27, 2015
(HealthDay)—Intraperitoneal (IP) chemotherapy offers lasting benefit for patients with advanced ovarian cancer, according to a study published online March 23 in the Journal of Clinical Oncology.

Favorable outcomes for vitiligo in nivolumab-treated melanoma

August 24, 2016
(HealthDay)—For patients with advanced melanoma, vitiligo occurrence is associated with favorable clinical outcome during nivolumab treatment, according to a study published online Aug. 11 in the Journal of Dermatology.

Recommended for you

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

An integrated approach to finding new treatments for breast cancer

December 12, 2018
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.